Kolexia
Le Brun-Ly Valerie Dermatologie
Le Brun-Ly Valerie
Dermatologie
Hôpital Dupuytren
Limoges, France
75 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Sarcomes Léiomyosarcome Métastase tumorale Récidive tumorale locale Adénocarcinome Tumeurs de l'oesophage Tumeurs du côlon Tumeurs stromales gastro-intestinales

Collaborateurs

Voir plus
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Bertucci Francois
Bertucci Francois
Centre Paoli-Calmettes, Marseille, France
Bompas Emmanuelle
Bompas Emmanuelle
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Penel Nicolas
Penel Nicolas
Centre Oscar-Lambret, Lille, France

Industries

Voir plus
Ipsen
6 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2023
Amgen
3 collaboration(s)
Dernière en 2022
Merck-Serono
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
CHIC-STS01: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   26 février 2024
EDEN: Prospective Therapeutic De-escalation and miRNA-M371 Biomarker Evaluation Phase II Study for Stage IIa/IIb < 3 cm Seminomas
Essai Clinique (Centre Léon-Bérard)   24 janvier 2024
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF -mutated melanoma.
ESMO open   01 novembre 2023
1913O A randomised, multicenter phase-III study comparing doxorubicin (dox) alone versus dox with trabectedin (trab) followed by trab in non-progressive patients (pts) as first-line therapy, in pts with metastatic or unresectable leiomyosarcoma (LMS): Final results of the LMS-04 study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
MIRAS: Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   22 septembre 2023
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA network open   05 septembre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital.
Frontiers in oncology   27 février 2023
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC.
BMC cancer   20 janvier 2023
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 septembre 2022